The Global Market for qPCR and dPCR Instrumentation is Projected to Reach US$4.9 Billion by 2024

Growing Demand for Genetic and Genomic Analysis to Drive the Global qPCR and dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market size, share and demand forecasts on the global qPCR and dPCR Instrumentation market. The global market for qPCR and dPCR Instrumentation is projected to reach US$4.9 billion by 2024, driven by growing geriatric population, rising incidence of genetic disorders, and rising investment in gene therapy and research.

Polymerase Chain Reaction (PCR) technology, an integral part of modern-day biology, is a technique used in amplifying DNA sequence and producing several copies of a particular DNA sequence. PCR is witnessing significant use in pharmaceutical research and diagnostic applications, including diagnosis of various diseases, development of novel therapies, profiling and forensics among others. PCR continues to dominate the global gene amplification technologies market, supported by roll out of several novel PCR instruments. The market for qPCR and dPCR instrumentation and reagents is expected to witness significant growth driven by increasing demand for genetic and genomic analysis in various end-use markets alongside other factors. Factors encouraging growth in the qPCR instruments and reagents market include the increasing availability of high-strength assays, higher demand for more throughput, access to inexpensive equipment, automation and multiplexed analytical strategies.

Real-time PCR (RT-PCR)/quantitative PCR (qPCR) represents the leading technology segment, with a wide ranging applications, ranging from academic research, disease diagnosis, and pharmacogenomics, to water and food quality testing and industrial microbiology. Digital PCR (dPCR), a relatively new technology, facilitates absolute quantification of nucleic acid sequences and provides higher accuracy and sensitivity when compared to qPCR. The widening application base for dPCR, alongside constant technical advancements in both chip and droplet dPCR, are expected to propel the market forward. However, certain technical limitations of qPCR and dPCR coupled with expensive nature of sophisticated PCR devices remain a major barrier to broader adoption of these technologies. Technological refinement is also a major driving factor, which is expected to continue into the near future. Technological advancements are giving rise to improved versions of qPCR and dPCR systems and consumables. Notable advancements including automation of the instruments, which made real-time analysis simpler and expand their applications, integrated systems that perform multiple tasks such as from preparation of sample through analysis, and inclusion of droplet technology in dPCR among others. 

As stated by the new market research report on qPCR and dPCR Instrumentation, the U.S. represents the largest market worldwide. Presence of numerous pharmaceutical firms in the country employing PCR testing to diagnose diseases and develop novel drugs along with growing investments into genetic research, aging population and others result in high demand for qPCR and dPCR instruments and reagents. However, Asia-Pacific represents the fastest growing market worldwide, with a CAGR of 6.9% through the analysis period. Increase in government and consumer per-capita spending on healthcare, expanding healthcare needs compounded by the medical tourism trend and the ensuing need to improve the quality of diagnosis and treatment are the major factors driving growth.

Major players in the market include Agilent Technologies, Inc., Becton, Dickinson and Company, BioFire Diagnostics, Inc., Bio-Rad Laboratories, Inc., Cepheid, Eppendorf AG, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, Promega Corporation, QIAGEN N.V., RainDance Technologies, Inc., Takara Bio, Inc., and Thermo Fisher Scientific Inc. among others. 

The research report titled “qPCR and dPCR Instrumentation: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for qPCR and dPCR Instrumentation in value terms for all major geographic markets such as United States, Canada, Japan, Europe (France, Germany, Italy, UK and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), Middle East & Africa, and Latin America. The report also analyzes the global and regional markets for qPCR and dPCR Instrumentation by the Product Categories - Reagents and Instruments. Product segments analyzed include qPCR and dPCR. The report also analyzes the global qPCR and dPCR Instrumentation market by the end-use segments Educational/Research, Testing Laboratories and Pharma.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.